Featured Research

from universities, journals, and other organizations

Lupus Discovery May Pave Way To Better-designed COX-2 Inhibitors

Date:
March 18, 2004
Source:
Northwestern University
Summary:
In an important development in the treatment of lupus as well as certain cancers, scientists at the Feinberg School of Medicine at Northwestern University have discovered how autoimmune lupus T cells stave off programmed cell death and drive production of autoantibodies directed against the body's own DNA.

In an important development in the treatment of lupus as well as certain cancers, scientists at the Feinberg School of Medicine at Northwestern University have discovered how autoimmune lupus T cells stave off programmed cell death and drive production of autoantibodies directed against the body's own DNA.

Related Articles


Syamal Datta, M.D., and colleagues found that lupus T cells increase production of an enzyme called cyclooxygenase 2 (COX-2), which helps trigger inflammation, in tandem with another molecule called c-FLIP, which then prevents the autoimmune T cells from self-destructing.

Using commonly prescribed drugs called COX-2 inhibitors, which suppress COX-2 activity and, as a result, inflammatory chemicals called prostaglandins, the Northwestern researchers caused autoimmune T cells to die and blocked lupus autoimmunity.

Results of their study, published in the April issue of Nature Medicine, may pave the way for the design of better COX-2 inhibitors with less kidney toxicity or other candidate drugs that interfere with the lupus T cell's death resistance pathway, said Datta, who is Solovy Professor of Medicine and professor of microbiology/immunology at the Feinberg School.

Currently, COX-2 inhibitors are widely prescribed to treat rheumatoid arthritis and other inflammatory conditions, and have been tested for use in a number of cancers, including colorectal cancer.

Most unexpectedly, the researchers found that only some COX-2 inhibitors have a beneficial effect in lupus, which may depend on their structural peculiarity and not because they inhibit prostaglandin production and reduce inflammation -- something all COX-2 inhibitors do.

COX-2 inhibitors also have been used, with limited success, to treat patients with lupus and in laboratory models of lupus, but in doses much lower than the concentration required to achieve cell death and elimination of autoimmune T cells, Datta said.

Datta's co-researchers were Luting Xu, Li Zhang, Yajun Yi and Hee-Kap Kang. Yajun Yi is now at Vanderbilt University, Nashville


Story Source:

The above story is based on materials provided by Northwestern University. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern University. "Lupus Discovery May Pave Way To Better-designed COX-2 Inhibitors." ScienceDaily. ScienceDaily, 18 March 2004. <www.sciencedaily.com/releases/2004/03/040317074740.htm>.
Northwestern University. (2004, March 18). Lupus Discovery May Pave Way To Better-designed COX-2 Inhibitors. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2004/03/040317074740.htm
Northwestern University. "Lupus Discovery May Pave Way To Better-designed COX-2 Inhibitors." ScienceDaily. www.sciencedaily.com/releases/2004/03/040317074740.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins